MétaCan
Menu
Back to cohort
Record W2002052963 · doi:10.1016/j.jalz.2012.05.1582

P3‐357: Design, synthesis, and biological evaluation of novel fused‐ring systems to treat Alzheimer's disease

2012· article· en· W2002052963 on OpenAlexaff
Wesseem Osman, Wanli Zhou, Victor Mun‐Sing Sit, Tarek Mohamed, Praveen P. N. Rao

Bibliographic record

VenueAlzheimer s & Dementia · 2012
Typearticle
Languageen
FieldMedicine
TopicCholinesterase and Neurodegenerative Diseases
Canadian institutionsUniversity of Waterloo
Fundersnot available
KeywordsChemistryButyrylcholinesteraseCombinatorial chemistryCholinesterasePharmacophoreAcetylcholinesteraseAntioxidantAcridineChelationStereochemistryEnzymeOrganic chemistryPharmacologyAché

Abstract

fetched live from OpenAlex

Evidence suggests that in order to prevent Alzheimer's disease (AD) progression one has to develop novel agents to target multiple AD pathways as disease-modifying agents. We are developing fused heterocyclic ring systems to target the cholinergic, metal and oxidative stress mediated neurotoxicity. Structure activity data for a library of novel heterocyclic molecules and their potential as disease-modifying agents will be presented. Computational/molecular modeling studies: The structure-based design (SBD) module is used to design novel fused ring systems and the ligand-enzyme binding interactions with monomeric human acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes are investigated. Synthetic Organic Chemistry: Currently, a synthetic protocol has been developed to prepare acridine derivatives. The synthesis involved reduction of nitro-substituted-benzoic acid derivatives to aminobenzoic acid derivatives which was reacted with cyclohexanone in presence of phosphorous oxychloride to obtain 9-chloro-substituted tetrahydroacridine intermediate which was further reacted with various peripheral anionic site and antioxidant pharmacophores to afford target molecules possessing varying steric and electronic properties Cholinesterase inhibition assay: Compounds are screened for inhibition of mammalian AChE and BuChE. The concentrations of the test compounds causing 50% inhibition (IC50, μM) are calculated.Metal chelation and antioxidant property evaluation: Metal-chelation ability is evaluated using UV spectroscopy whereas antioxidant properties are evaluated using oxygen radical absorbance capacity assay (ORAC-FL). We have synthesized compounds that were characterized via analytical techniques including nuclear magnetic spectroscopy and mass spectrometry. Purity of the compounds is assessed by HPLC analysis. Anticipated results will include a library of acridine derivatives varying in chemical and physical properties. Molecular modeling studies have indicated the central fused acridine ring undergoes favourable interactions within the catalytic site of AChE enzyme. Preliminary data on their ability to inhibit both AChE and BuChEs, their ability to chelate metals and antioxidant properties along with detailed enzyme-ligand binding investigations will be discussed.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.010

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.199
GPT teacher head0.356
Teacher spread0.157 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2012
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicCholinesterase and Neurodegenerative DiseasesFrench-language works237,207